These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20349780)

  • 1. Prediction of suboptimal cytoreduction of epithelial ovarian carcinoma by preoperative computed tomography.
    Kebapci M; Akca AK; Yalcin OT; Ozalp SS; Calisir C; Mutlu F
    Eur J Gynaecol Oncol; 2010; 31(1):44-9. PubMed ID: 20349780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
    Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
    Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings.
    Kim HJ; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):343-7. PubMed ID: 25286788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.
    Nelson BE; Rosenfield AT; Schwartz PE
    J Clin Oncol; 1993 Jan; 11(1):166-72. PubMed ID: 8418230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.
    Qayyum A; Coakley FV; Westphalen AC; Hricak H; Okuno WT; Powell B
    Gynecol Oncol; 2005 Feb; 96(2):301-6. PubMed ID: 15661212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
    Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Iyer RB; Zhou Q; Iasonos A; Denesopolis J; Zivanovic O; Long Roche KC; Sonoda Y; Coleman RL; Abu-Rustum NR; Hricak H; Chi DS
    Gynecol Oncol; 2017 Apr; 145(1):27-31. PubMed ID: 28209497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.
    Dowdy SC; Mullany SA; Brandt KR; Huppert BJ; Cliby WA
    Cancer; 2004 Jul; 101(2):346-52. PubMed ID: 15241833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer.
    Gerestein CG; Eijkemans MJ; Bakker J; Elgersma OE; van der Burg ME; Kooi GS; Burger CW
    Anticancer Res; 2011 Nov; 31(11):4043-9. PubMed ID: 22110240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.
    Axtell AE; Lee MH; Bristow RE; Dowdy SC; Cliby WA; Raman S; Weaver JP; Gabbay M; Ngo M; Lentz S; Cass I; Li AJ; Karlan BY; Holschneider CH
    J Clin Oncol; 2007 Feb; 25(4):384-9. PubMed ID: 17264334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patients.
    Pectasides D; Kayianni H; Facou A; Bobotas N; Barbounis V; Zis J; Athanassiou A
    Am J Clin Oncol; 1991 Dec; 14(6):457-62. PubMed ID: 1957833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
    Lou FL; Shi YF
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study.
    Rizzo S; De Piano F; Buscarino V; Pagan E; Bagnardi V; Zanagnolo V; Colombo N; Maggioni A; Del Grande M; Del Grande F; Bellomi M; Aletti G
    Eur J Radiol; 2020 Feb; 123():108786. PubMed ID: 31862634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of computed tomography in predicting cytoreductive surgical outcomes for ovarian cancer.
    Fujwara K; Yoshino K; Enomoto T; Fujita M; Ueda Y; Miyatake T; Kimura T; Muraji M; Fujita H; Kimura T; Hori M
    Arch Gynecol Obstet; 2011 Dec; 284(6):1501-7. PubMed ID: 21347681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study.
    Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
    Gynecol Oncol; 2008 Feb; 108(2):265-70. PubMed ID: 18055006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.
    Alessi A; Martinelli F; Padovano B; Serafini G; Lorusso D; Lorenzoni A; Ditto A; Lecce F; Mira M; Donfrancesco C; Raspagliesi F; Crippa F
    Tumori; 2016; 102(1):103-7. PubMed ID: 26350201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study.
    Testa AC; Ludovisi M; Mascilini F; Di Legge A; Malaggese M; Fagotti A; Fanfani F; Salerno MG; Ercoli A; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):99-105. PubMed ID: 21913276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and quantification of peritoneal metastases in patients with ovarian cancer with multidetector computed tomography: correlation with surgery and surgical outcome.
    Metser U; Jones C; Jacks LM; Bernardini MQ; Ferguson S
    Int J Gynecol Cancer; 2011 Nov; 21(8):1391-8. PubMed ID: 21997169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer.
    Chong GO; Jeong SY; Lee YH; Lee HJ; Lee SW; Han HS; Hong DG; Lee YS
    J Ovarian Res; 2019 Feb; 12(1):12. PubMed ID: 30717813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer.
    Gemer O; Gdalevich M; Ravid M; Piura B; Rabinovich A; Gasper T; Khashper A; Voldarsky M; Linov L; Ben Shachar I; Anteby EY; Lavie O
    Eur J Surg Oncol; 2009 Oct; 35(10):1109-12. PubMed ID: 19329270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.